A Population Pharmacokinetic Analysis of the Influence of Nutritional Status of Digoxin in Hospitalized Korean Patients

被引:5
作者
Choi, Soo An [1 ]
Yun, Hwi-yeol [2 ]
Lee, Eun Sook [1 ]
Shin, Wan Gyoon [3 ,4 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pharm, Seoul 110799, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Taejon, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul 110799, South Korea
[4] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 110799, South Korea
关键词
digoxin; nonlinear mixed-effects modeling; NONMEM; nutritional status; population pharmacokinetics; SKELETAL-MUSCLE MASS; ELDERLY-PATIENTS; RENAL-FAILURE; TOXICITY; NONMEM; MODEL; POLYMORPHISM; CLEARANCE; KINETICS; THERAPY;
D O I
10.1016/j.clinthera.2014.01.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Safe and effective use of digoxin in hospitalized populations requires information about the drug's pharmacokinetics and the influence of various factors on drug disposition. However, no attempts have been made to link an individual's digoxin requirements with nutritional status. Objectives: The main goal of this study was to estimate the population pharmacokinetics of digoxin and to identify the nutritional status that explains pharmacokinetic variability in hospitalized Korean patients. Methods: Routine therapeutic drug-monitoring data from 106 patients who received oral digoxin at Seoul National University Bundang Hospital were retrospectively collected. The pharmacokinetics of digoxin were analyzed with a 1-compartment, open-label pharmacokinetic model by using a nonlinear mixed-effects modeling tool (NONMEM) and a multiple trough screening approach. Results: The effect of demographic characteristics and biochemical and nutritional indices were explored. Estimates generated by using NONMEM indicated that the CL/F of digoxin was influenced by renal function, serum potassium, age, and percentage of ideal body weight (MEW). These influences could be modeled by following the equation CL/F (L/h) = 1.36 x (creatinine clearance/50)(1.580) x K-0.835 x 0.055 x (age/65) x (PIBW/100)(0.403). The interindividual %CV for CL/F was 34.3%, and the residual variability (SD) between observed and predicted concentrations was 0.225 mu g/L. The median estimates from a bootstrap procedure were comparable and within 5% of the estimates from NONMEM. Correlation analysis with the validation group showed a linear correlation between observed and predicted values. Conclusions: The use of this model in routine therapeutic drug monitoring requires that certain conditions be met which are consistent with the conditions of the subpopulations in the present study. Therefore, further studies are needed to clarify the effects of nutritional status on digoxin pharmacokinetics. The present study established important sources of variability in digoxin pharmacokinetics and highlighted the relationship between pharmacokinetic parameters and nutritional status in hospitalized Korean patients. (C) 2014 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:389 / 400
页数:12
相关论文
共 49 条
  • [1] Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity
    Abad-Santos, F
    Carcas, AJ
    Ibáñez, C
    Frias, J
    [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (02) : 163 - 168
  • [2] [Anonymous], 2018, Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
  • [3] ALTERED DISTRIBUTION OF DIGOXIN IN RENAL-FAILURE - CAUSE OF DIGOXIN TOXICITY
    ARONSON, JK
    GRAHAMESMITH, DG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) : 1045 - 1051
  • [4] Beal SL, 1998, NONMEM USER GUIDES N
  • [5] Population pharmacokinetics of digoxin in elderly patients
    Chen, Rong
    Zou, Su-lan
    Wang, Ming-li
    Jiang, Yan
    Xue, Hui
    Qian, Chun-yan
    Xia, Zong-ling
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2013, 38 (02) : 115 - 121
  • [6] Cheng JWM, 1997, PHARMACOTHERAPY, V17, P584
  • [7] Skeletal muscle and nutritional assessment in chronic renal failure patients on a protein-restricted diet
    Cupisti, A
    Licitra, R
    Chisari, C
    Stampacchia, G
    D'Alessandro, C
    Galetta, F
    Rossi, B
    Barsotti, G
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 255 (01) : 115 - 124
  • [8] DISTRIBUTION AND CONCENTRATION OF TRITIATED DIGOXIN IN HUMAN TISSUES
    DOHERTY, JE
    PERKINS, WH
    FLANIGAN, WJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1967, 66 (01) : 116 - +
  • [9] EL Desoky Ehab S, 2002, Am J Ther, V9, P492, DOI 10.1097/00045391-200211000-00006
  • [10] Development of a model based on body composition to predict drug kinetics II. Application of the model to the use of digoxin in elderlies
    Ferrara, S
    Pazzucconi, F
    Bondioli, A
    Mombelli, G
    Agrati, A
    Ferraro, G
    Zoppi, F
    De Rosa, C
    Calabresi, L
    Sirtori, CR
    [J]. PHARMACOLOGICAL RESEARCH, 2004, 50 (01) : 105 - 108